stars 1 stars 2 stars 3

ZENDAL is an international biopharmaceutical group with a solid track record in the development and production of vaccines, pharmaceutical products, and probiotics for both human and animal health. With a presence in over 65 countries, we are committed to delivering effective and innovative health solutions through a strong scientific and technological vision aligned with global health challenges. In recent years, ZENDAL has strengthened its leadership through strategic investment in R&D, new biopharmaceutical infrastructures, and corporate growth. This commitment has translated into enhanced technical and production capabilities in biotechnology, significantly expanding our global reach. Driven by a strong spirit of innovation, ZENDAL continues to move forward with the goal of anticipating major global health challenges. We are committed to talent, innovation, and purpose as the key pillars to continue protecting health through high-impact biotechnological solutions.

ZENDAL Questions

The ZENDAL annual revenue was $35.5 million in 2026.

Ricardo García-Cambón is the CPO - Director de Compras del Grupo of ZENDAL.

153 people are employed at ZENDAL.

ZENDAL is based in Torneiros, Galicia.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users